ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1981

Patients with Inflammatory Arthritis Who Are More Adherent to Treatment Do Not Perform More Physical Activity Collected by Smartphone Apps: A Cross-sectional Study of 101 Patients, the ImBAIA Study

Thomas Davergne1, Rawdha Tekaya2, Camille Deprouw3, Anne Tournadre4, Stéphane Mitrovic5, Adeline Ruyssen-Witrand6, Christophe Hudry7, Sabrina Dadoun8, Jérôme Avouac9, Kate Betteridge10, Bruno Fautrel11 and Laure Gossec12, 1Sorbonne University, INSERM, IPLES, Paris, France, 2Hôpital Charles Nicolle, Rheumatology department, Tunis, Tunisia, Tunis, Tunisia, 31. AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012, France, Paris, France, 4CHU Gabriel Montpied, Clermont-Ferrand, 5Institut Mutualiste Montsouris, Rheumatology department, Paris, France, Paris, Ile-de-France, France, 6Hôpital Purpan, CHU Toulouse, Toulouse, France, 7CeSOA, MGEN, Paris, France, Paris, Ile-de-France, France, 8Medical centre, Paris, France, paris, Ile-de-France, France, 9Cochin hospital, Rheumatology department, Paris, France, Paris, Ile-de-France, France, 10Patient research partner, UK, london, England, United Kingdom, 11Sorbonne University, INSERM, IPLES; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France, 12Sorbonne University, INSERM; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France

Meeting: ACR Convergence 2020

Keywords: Adhesion, Adhesion molecules, physical activity, Psoriatic arthritis, rheumatoid arthritis, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Patient Outcomes, Preferences, & Attitudes II: Engagement, Perceptions, & Quality of Life (1978–1982)

Session Type: Abstract Session

Session Time: 11:00AM-11:50AM

Background/Purpose: Adherence to both medications and physical activity is insufficient in patients with inflammatory arthritis (IA), such as spondyloarthritis (axSpA), rheumatoid arthritis (RA) or psoriatic arthritis (PsA). Are there patterns towards adherence to both of these aspects of management?

Objectives: to assess and compare adherence to medication and levels of physical activity collected through Apps, in patients with IA.

Methods: This was an international, multicentric, cross-sectional study performed between October 2019 and June 2020 (ClinicalTrial NCT04426747). Consecutive patients were included if they had definite axSpA, RA or PsA, were aged above 18 and able to walk, with smartphones compatible with Apps measuring steps. Adherence to medication was assessed using the Medication Adherence Report Scale MARS-9 (ranging from 9 to 45 with higher scores indicating higher adherence). Physical activity was measured by steps per day over the past week, through the patient’s smartphone apps. The link between the MARS-9 score and physical activity was assessed by linear and logistic regression. For the logistic regression, patients were considered less adherent for the lowest tertile of the MARS score. They were compared to more adherent patients by univariable and multivariable logistic regression. There was no imputation of missing data.

Results: Of 130 patients included, 101 had analyzable data (46 (46%) axSpA, 26 (26%) RA, 27 (27%) PsA). Mean age was 45.2 years (standard deviation 13.1), mean disease duration 10.0 (8.5) years and 47% were women. 67% were receiving a biologic, and disease activity was moderate. Adherence to medication was high: the mean MARS score was 38.9 (7.0) with a median of 41. Physical activity was moderate: the mean steps per day collected with apps was 5631 (4286), median 4244 with 29% walking over 7000 steps per day. The linear regression between adherence to medications and steps per day did not indicate a link (R=-0.04, p=0.72). Furthermore, patients with a lower adherence to medication (lowest tertile scores, ie, < =38) did not differ in terms of physical activity 5703 (4014) versus 5602 (4419) steps per day, p=0.80 in multivariable analysis.

Conclusion: In this population of long-standing IA, adherence to medication was high whereas physical activity was insufficient. Patients with IA who were more adherent to treatment were not more physically active than those less adherent. Adherence to medication and adherence to lifestyle changes may be linked to different coping mechanisms.


Disclosure: T. Davergne, None; R. Tekaya, None; C. Deprouw, None; A. Tournadre, None; S. Mitrovic, None; A. Ruyssen-Witrand, None; C. Hudry, None; S. Dadoun, None; J. Avouac, None; K. Betteridge, None; B. Fautrel, MSD France, 1, 2, Abbvie, 1, 2, Pfizer, 1, 2, Biogen, 1, BMS, 1, Boehringer Ingelheim, 1, Celgene, 1, Janssen, 1, Lilly, 1, Medac, 1, Nordic Pharma, 1, Novartis, 1, Roche, 1, Sanofi-Aventis, 1, SOBI, 1, UCB Pharma, 1; L. Gossec, None.

To cite this abstract in AMA style:

Davergne T, Tekaya R, Deprouw C, Tournadre A, Mitrovic S, Ruyssen-Witrand A, Hudry C, Dadoun S, Avouac J, Betteridge K, Fautrel B, Gossec L. Patients with Inflammatory Arthritis Who Are More Adherent to Treatment Do Not Perform More Physical Activity Collected by Smartphone Apps: A Cross-sectional Study of 101 Patients, the ImBAIA Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/patients-with-inflammatory-arthritis-who-are-more-adherent-to-treatment-do-not-perform-more-physical-activity-collected-by-smartphone-apps-a-cross-sectional-study-of-101-patients-the-imbaia-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-inflammatory-arthritis-who-are-more-adherent-to-treatment-do-not-perform-more-physical-activity-collected-by-smartphone-apps-a-cross-sectional-study-of-101-patients-the-imbaia-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology